 |
Service |
|
|
||||
| FLYLIFE manufactures recombinant proteins at industrial scale, using insect larvae as biofactories. We offer customized manufacturing contracts (CMO) for pharmaceutical, biotechnology, veterinary, and diagnostic companies | ||||
| Large scale recombinant protein expression in a high-versatile system. The system is based on caterpillars as mini-disposable biofactories using a Baculovirus Expression Vector System (BEVS) technology. Economically rational approach to be prepared to halt pandemic or bioalarms at a local basis. A multiproduct FLYLIFE-based manufacturing plant shows: - Low capital investment and low fixed costs - Minimum space demand - High-versatile protein expression - High yield - High scale-up speed. Delivering first batch in less than 12 weeks - Biological safety. Devoid compounds of animal origin Designed to fully compliance with EMEA and FDA cGMP guidelines. For human and animal applications. |
||||
|
||||
|
Permalink
|
||||
|
||||
| Search | ||
 |
||
|
||
 |
||
| BioRegión Collaborative Area | ||
| RSS | ||
|
||
|
||
| User Acces | ||
|
||
| Companies/centers Acces | ||
|
||
| Tag cloud | ||
|
||
|
|
